Royalty Pharma Plc (NASDAQ:RPRX) is a top biotech stock with positive analyst ratings and growth potential. Analysts cite its diverse portfolio and strategic positioning as key strengths. The company collaborates with various biopharma entities and holds royalties in numerous commercial products.